Thermo Fisher to buy Qiagen for $11.5bn
03-03-2020
Catalent to buy $1.2bn gene therapy company
17-04-2019
Thermo Fisher to acquire electron microscopy company for $4.2bn
31-05-2016
testing / Shutterstock.com
Biotech company Thermo Fisher Scientific has announced plans to acquire Brammer Bio, a viral vector manufacturer for gene and cell therapies, for $1.7 billion.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Thermo Fisher Scientific, Brammer Bio, M&A, mergers and acquisitions, gene therapy, genetics, genetic disorders
